Pentwater Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Pentwater Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-92,500	Closed	-$1.69M	–	238
2021 Q4	$1.69M	Hold	92,500	–	–	0.02%	145
2021 Q3	$1.1M	Hold	92,500	–	–	0.01%	182
2021 Q2	$1.59M	Hold	92,500	–	–	0.01%	181
2021 Q1	$1.69M	Hold	92,500	–	–	0.02%	191
2020 Q4	$1.74M	Buy	92,500 +2,500	+3%	+$53.9K	0.02%	133
2020 Q3	$1.9M	Hold	90,000	–	–	0.02%	125
2020 Q2	$2.6M	Buy	90,000 +70,000	+350%	+$2.11M	0.05%	74
2020 Q1	$700K	Buy	20,000 +9,600	+92%	+$311K	0.01%	99
2019 Q4	$254K	Buy	+10,400	New	+$183K	﹤0.01%	139

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pentwater Capital Management's OYST Position: Q1 2022 in Review

Pentwater Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022, closing a stake of 92,500 shares — an estimated $1.69M sold.

Pentwater Capital Management first reported a position in OYST in Q4 2019 and held it in 9 quarters. The position peaked at $2.6M in Q2 2020. 72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

Pentwater Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Pentwater Capital Management sold 92,500 Oyster Point Pharma, Inc. Common Stock shares in Q1 2022, an estimated $1.69M.
Pentwater Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
Pentwater Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $2.6M in Q2 2020.
72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Pentwater Capital Management's 13F filing for Q1 2022, filed 16 May 2022.